Weekly ibandronic acid prevents postmenopausal bone loss

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1406, 2003-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risedronic acid prevents bone loss in postmenopausal women with breast cancer, with or without aromatase inhibitor (AI) therapy,

By  

Inpharma, Vol. 1, Iss. 1637, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

MOTION supports ibandronic acid in postmenopausal osteoporosis

By  

Inpharma, Vol. 1, Iss. 1611, 2007-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Ibandronic acid gives a bone in cancer metastases

By  

Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Ibandronic acid beneficial in metastatic bone disease

By  

Inpharma, Vol. 1, Iss. 1437, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Ibandronic Acid: A Review of its Use in the Treatment of Bone Metastases of Breast Cancer

By McCormack Paul L.   Plosker Greg L.  

Drugs, Vol. 66, Iss. 5, 2006-01 ,pp. : 711-728

Adis International

Access to resources Recommend Favorite